Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > Capital Expenditures

Rhythm Pharmaceuticals Inc Capital Expenditures Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly Capital Expenditures from 2017 to 2018.
  • Rhythm Pharmaceuticals Inc Capital Expenditures for the quarter ending September 09, 2018 was $0m a 75.39% decrease of 0m year over year
  • Rhythm Pharmaceuticals Inc Capital Expenditures for the last 12 months ending September 09, 2018 was $0m a 65.18% decrease of 0m year over year
  • Rhythm Pharmaceuticals Inc Annual Capital Expenditures for 2017 was $0m a -694.74% increase of 1m from 2016
  • Rhythm Pharmaceuticals Inc Annual Capital Expenditures for 2016 was $-1m a 98.39% decrease of -1m from 2015
  • Rhythm Pharmaceuticals Inc Annual Capital Expenditures for 2015 was $0m
Other Cash Flow Metrics:
  • Rhythm Pharmaceuticals Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-17m a 53.46% decrease of -9m year over year
  • Rhythm Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-13m a 53.57% decrease of -7m year over year
View Chart On Koyfin

Quarterly RYTM Capital Expenditures Data

09/2018$0m
06/2018$0m
12/2017$0m
09/2017$0m

Annual RYTM Capital Expenditures Data

2017$0m
2016$-1m
2015$0m